Geriatric assessment for the practicing clinician: The why, what, and how.
aging
geriatric assessment
geriatric oncology
treatment‐related toxicity
Journal
CA: a cancer journal for clinicians
ISSN: 1542-4863
Titre abrégé: CA Cancer J Clin
Pays: United States
ID NLM: 0370647
Informations de publication
Date de publication:
29 Aug 2024
29 Aug 2024
Historique:
revised:
25
07
2024
received:
04
06
2024
accepted:
29
07
2024
medline:
31
8
2024
pubmed:
31
8
2024
entrez:
29
8
2024
Statut:
aheadofprint
Résumé
Older adults with cancer heterogeneously experience health care, treatment, and symptoms. Geriatric assessment (GA) offers a comprehensive evaluation of an older individual's health status and can predict cancer-related outcomes in individuals with solid tumors and those with hematologic malignancies. In the last decade, randomized controlled trials have demonstrated the benefits of GA and GA management (GAM), which uses GA information to provide tailored intervention strategies to address GA impairments (e.g., implementing physical therapy for impaired physical function). Multiple phase 3 clinical trials in older adults with solid tumors and hematologic malignancies have demonstrated that GAM improves treatment completion, quality of life, communication, and advance care planning while reducing treatment-related toxicity, falls, and polypharmacy. Nonetheless, implementation and uptake of GAM remain challenging. Various strategies have been proposed, including the use of GA screening tools, to identify patients most likely to benefit from GAM, the systematic engagement of the oncology workforce in the delivery of GAM, and the integration of technologies like telemedicine and mobile health to enhance the availability of GA and GAM interventions. Health inequities in minoritized groups persist, and systematic GA implementation has the potential to capture social determinants of health that are relevant to equitable care. Caregivers play an important role in cancer care and experience burden themselves. GA can guide dyadic supportive care interventions, ultimately helping both patients and caregivers achieve optimal health.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : National Institute on Aging
ID : K76 AG064394
Organisme : National Institute on Aging
ID : R0I AG077053
Organisme : National Institute on Aging
ID : K01AG068592
Organisme : National Institute on Aging
ID : R03AG073985
Organisme : National Institute on Aging
ID : R33 AG059206
Organisme : National Institute on Aging
ID : K24AG056589
Organisme : National Cancer Institute
ID : K01CA276257
Organisme : National Cancer Institute
ID : R00CA237744
Organisme : Bristol Myers Squibb Foundation
Organisme : Conquer Cancer Foundation American Society of Clinical Oncology-Walther Cancer Foundation Career Development Award
Organisme : Patient-Centered Outcomes Research Institute
ID : DI-2020C3-21003
Organisme : American Cancer Society
ID : MRSG-18-225-01-CPPB
Informations de copyright
© 2024 The Author(s). CA: A Cancer Journal for Clinicians published by Wiley Periodicals LLC on behalf of American Cancer Society.
Références
Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649‐656. doi:10.1097/00000421‐198212000‐00014
Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM, ed. Evaluation of Chemotherapeutic Agents. Columbia University Press; 1949:191‐205.
Hurria A, Togawa K, Mohile SG, et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol. 2011;29(25):3457‐3465. doi:10.1200/JCO.2011.34.7625
Taylor AE, Olver IN, Sivanthan T, Chi M, Purnell C. Observer error in grading performance status in cancer patients. Support Care Cancer. 1999;7(5):332‐335. doi:10.1007/s005200050271
Kelly CM, Shahrokni A. Moving beyond Karnofsky and ECOG performance status assessments with new technologies. J Oncol. 2016;2016:1‐13. doi:10.1155/2016/6186543
Jolly TA, Deal AM, Nyrop KA, et al. Geriatric assessment‐identified deficits in older cancer patients with normal performance status. Oncologist. 2015;20(4):379‐385. doi:10.1634/theoncologist.2014‐0247
Broderick JM, Hussey J, Kennedy MJ, O' Donnell DM. Patients over 65 years are assigned lower ECOG PS scores than younger patients, although objectively measured physical activity is no different. J Geriatr Oncol. 2014;5(1):49‐56. doi:10.1016/j.jgo.2013.07.010
Magnuson A, Bruinooge SS, Singh H, et al. Modernizing clinical trial eligibility criteria: recommendations of the ASCO–Friends of Cancer Research Performance Status Work Group. Clin Cancer Res. 2021;27(9):2424‐2429. doi:10.1158/1078‐0432.CCR‐20‐3868
Hurria A, Gupta S, Zauderer M, et al. Developing a cancer‐specific geriatric assessment: a feasibility study. Cancer. 2005;104(9):1998‐2005. doi:10.1002/cncr.21422
Dale W, Klepin HD, Williams GR, et al. Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO guideline update. J Clin Oncol. 2023;41(26):4293‐4312. doi:10.1200/jco.23.00933
Wildiers H, Heeren P, Puts M, et al. International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol. 2014;32(24):2595‐2603. doi:10.1200/jco.2013.54.8347
Biganzoli L, Battisti NML, Wildiers H, et al. Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG). Lancet Oncol. 2021;22(7):e327‐e340. doi:10.1016/s1470‐2045(20)30741‐5
Mottet N, Ribal MJ, Boyle H, et al. Management of bladder cancer in older patients: position paper of an SIOG Task Force. J Geriatr Oncol. 2020;11(7):1043‐1053. doi:10.1016/j.jgo.2020.02.001
Kanesvaran R, Le Saux O, Motzer R, et al. Elderly patients with metastatic renal cell carcinoma: position paper from the International Society of Geriatric Oncology. Lancet Oncol. 2018;19(6):e317‐e326. doi:10.1016/s1470‐2045(18)30125‐6
Extermann M, Artz A, Rebollo MA, et al. Treating acute myelogenous leukemia in patients aged 70 and above: recommendations from the International Society of Geriatric Oncology (SIOG). J Geriatr Oncol. 2024;15(2):101626. doi:10.1016/j.jgo.2023.101626
Klepin HD, Neuendorff NR, Larson RA, et al. Treatment of acute promyelocytic leukemia in older patients: recommendations of an International Society of Geriatric Oncology (SIOG) Task Force. J Geriatr Oncol. 2020;11(8):1199‐1209. doi:10.1016/j.jgo.2020.03.019
Stauder R, Eichhorst B, Hamaker ME, et al. Management of chronic lymphocytic leukemia (CLL) in the elderly: a position paper from an international Society of Geriatric Oncology (SIOG) Task Force. Ann Oncol. 2017;28(2):218‐227. doi:10.1093/annonc/mdw547
Mohile SG, Dale W, Somerfield MR, et al. Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology. J Clin Oncol. 2018;36(22):2326‐2347. doi:10.1200/JCO.2018.78.8687
Dotan E, Walter LC, Browner IS, et al. NCCN Guidelines® Insights: Older Adult Oncology, version 1.2021. J Natl Compr Canc Netw. 2021;19(9):1006‐1019. doi:10.6004/jnccn.2021.0043
Dale W, Williams GR, Amy RM, et al. How Is geriatric assessment used in clinical practice for older adults with cancer? A survey of cancer providers by the American Society of Clinical Oncology. JCO Oncol Pract. 2021;17(6):336‐344. doi:10.1200/op.20.00442
Hurria A, Mohile S, Gajra A, et al. Validation of a prediction tool for chemotherapy toxicity in older adults with cancer. J Clin Oncol. 2016;34(20):2366‐2371. doi:10.1200/JCO.2015.65.4327
Mohamed MR, Loh KP, Mohile SG, et al. External validation of risk factors for unplanned hospitalization in older adults with advanced cancer receiving chemotherapy. J Natl Compr Canc Netw. 2023;21(3):273‐280.e3. doi:10.6004/jnccn.2022.7094
Wildes TM, Maggiore RJ, Tew WP, et al. Factors associated with falls in older adults with cancer: a validated model from the Cancer and Aging Research Group. Support Care Cancer. 2018;26(10):3563‐3570. doi:10.1007/s00520‐018‐4212‐3
Pang A, Jiali L, Ng A, et al. Use of the Cancer and Aging Research Group predictive model for chemotherapy‐related toxic effects in a multiethnic, older adult Asian population. JAMA Netw Open. 2022;5(10):e2237196. doi:10.1001/jamanetworkopen.2022.37196
Suto H, Inui Y, Okamura A. Validity of the Cancer and Aging Research Group predictive tool in older Japanese patients. Cancers (Basel). 2022;14(9)2075. doi:10.3390/cancers14092075
Alibhai SMH, Breunis H, Hansen AR, et al. Examining the ability of the Cancer and Aging Research Group tool to predict toxicity in older men receiving chemotherapy or androgen‐receptor‐targeted therapy for metastatic castration‐resistant prostate cancer. Cancer. 2021;127(14):2587‐2594. doi:10.1002/cncr.33523[
Nishijima TF, Deal AM, Williams GR, Sanoff HK, Nyrop KA, Muss HB. Impact of the Cancer and Aging Research Group score and treatment intensity on survival and toxicity outcomes in older adults with advanced noncolorectal gastrointestinal cancers. Cancer. 2022;128(10):1929‐1936. doi:10.1002/cncr.34135[
Moth EB, Kiely BE, Stefanic N, et al. Predicting chemotherapy toxicity in older adults: comparing the predictive value of the CARG Toxicity Score with oncologists' estimates of toxicity based on clinical judgement. J Geriatr Oncol. 2019;10(2):202‐209. doi:10.1016/j.jgo.2018.08.010[
Magnuson A, Sedrak MS, Gross CP, et al. Development and validation of a risk tool for predicting severe toxicity in older adults receiving chemotherapy for early‐stage breast cancer. J Clin Oncol. 2021;39(6):608‐618. doi:10.1200/JCO.20.02063[
Sedrak MS, Sun CL, Ji J, et al. Low‐intensity adjuvant chemotherapy for breast cancer in older women: results from the prospective multicenter HOPE trial. J Clin Oncol. 2023;41(2):316‐326. doi:10.1200/JCO.22.01440[
Extermann M, Boler I, Reich RR, et al. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High‐Age Patients (CRASH) score. Cancer. 2012;118(13):3377‐3386. doi:10.1002/cncr.26646[
Rosko AE, Wall SA, Huang Y, et al. Evaluating the CARG chemotherapy toxicity calculator among older adults newly diagnosed with hematologic malignancy [abstract]. Blood. 2021;138(suppl 1):1931. doi:10.1182/blood‐2021‐153850
Mariano C, Jamal R, Bains P, et al. Utility of a chemotherapy toxicity prediction tool for older patients in a community setting. Curr Oncol. 2019;26(4):234‐239. doi:10.3747/co.26.4869[
Ortland I, Mendel Ott M, Kowar M, et al. Comparing the performance of the CARG and the CRASH score for predicting toxicity in older patients with cancer. J Geriatr Oncol. 2020;11(6):997‐1005. doi:10.1016/j.jgo.2019.12.016[
Klepin HD, Geiger AM, Tooze JA, et al. Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia. Blood. 2013;121(21):4287‐4294. doi:10.1182/blood‐2012‐12‐471680
Min GJ, Cho BS, Park SS, et al. Geriatric assessment predicts nonfatal toxicities and survival for intensively treated older adults with AML. Blood. 2022;139(11):1646‐1658. doi:10.1182/blood.2021013671
Saad M, Loh KP, Tooze JA, et al. Geriatric assessment and survival among older adults receiving postremission therapy for acute myeloid leukemia. Blood. 2020;136(23):2715‐2719. doi:10.1182/blood.2020005498
Molga A, Wall M, Chhetri R, et al. Comprehensive geriatric assessment predicts azacitidine treatment duration and survival in older patients with myelodysplastic syndromes. J Geriatr Oncol. 2020;11(1):114‐120. doi:10.1016/j.jgo.2019.02.002
Evens AM, Advani RH, Helenowski IB, et al. Multicenter phase II study of sequential brentuximab vedotin and doxorubicin, vinblastine, and dacarbazine chemotherapy for older patients with untreated classical Hodgkin lymphoma. J Clin Oncol. 2018;36(30):3015‐3022. doi:10.1200/JCO.2018.79.0139
Nabhan C, Smith SM, Helenowski I, et al. Analysis of very elderly (≥80 years) non‐Hodgkin lymphoma: impact of functional status and co‐morbidities on outcome. Br J Haematol. 2012;156(2):196‐204. doi:10.1111/j.1365‐2141.2011.08934.x
Tucci A, Martelli M, Rigacci L, et al. Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B‐cell lymphoma: a prospective multicenter evaluation in 173 patients by the Lymphoma Italian Foundation (FIL). Leuk Lymphoma. 2015;56(4):921‐926. doi:10.3109/10428194.2014.953142
Johnson PC, Woyach JA, Ulrich A, et al. Geriatric assessment measures are predictive of outcomes in chronic lymphocytic leukemia. J Geriatr Oncol. 2023;14(6):101538. doi:10.1016/j.jgo.2023.101538
Palumbo A, Bringhen S, Mateos MV, et al. Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report. Blood. 2015;125(13):2068‐2074. doi:10.1182/blood‐2014‐12‐615187
Olin RL, Fretham C, Pasquini MC, et al. Geriatric assessment in older alloHCT recipients: association of functional and cognitive impairment with outcomes. Blood Adv. 2020;4(12):2810‐2820. doi:10.1182/bloodadvances.2020001719
Muffly LS, Kocherginsky M, Stock W, et al. Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients. Haematologica. 2014;99(8):1373‐1379. doi:10.3324/haematol.2014.103655
Sorror ML, Storer BE, Nyland J, Estey EH. Revised acute myeloid leukemia composite model using the 2017 European LeukemiaNet Risk classification. JAMA Oncol. 2019;5(7):1062. doi:10.1001/jamaoncol.2019.0902
Sorror ML, Storer BE, Fathi AT, et al. Development and validation of a novel acute myeloid leukemia–composite model to estimate risks of mortality. JAMA Oncol. 2017;3(12):1675. doi:10.1001/jamaoncol.2017.2714
Wan BA, Nazha A, Starkman R, et al. Revised 15‐item MDS‐specific frailty scale maintains prognostic potential. Leukemia. 2020;34(12):3434‐3438. doi:10.1038/s41375‐020‐01026‐y
Mozessohn L, Li Q, Liu N, et al. Impact of frailty on health care resource utilization and costs of care in myelodysplastic syndromes. JCO Oncol Pract. 2023;19(4):e559‐e569. doi:10.1200/OP.22.00668
Starkman R, Alibhai S, Wells RA, et al. An MDS‐specific frailty index based on cumulative deficits adds independent prognostic information to clinical prognostic scoring. Leukemia. 2020;34(5):1394‐1406. doi:10.1038/s41375‐019‐0666‐7
Engelhardt M, Domm AS, Dold SM, et al. A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients. Haematologica. 2017;102(5):910‐921. doi:10.3324/haematol.2016.162693[
Facon T, Dimopoulos MA, Meuleman N, et al. A simplified frailty scale predicts outcomes in transplant‐ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM‐020) trial. Leukemia. 2020;34(1):224‐233. doi:10.1038/s41375‐019‐0539‐0
Merli F, Luminari S, Tucci A, et al. Simplified geriatric assessment in older patients with diffuse large B‐cell lymphoma: the Prospective Elderly Project of the Fondazione Italiana Linfomi. J Clin Oncol. 2021;39(11):1214‐1222. doi:10.1200/JCO.20.02465
Oiwa K, Fujita K, Lee S, et al. Utility of the Geriatric 8 for the prediction of therapy‐related toxicity in older adults with diffuse large B‐cell lymphoma. Oncologist. 2021;26(3):215‐223. doi:10.1002/onco.13641
Lee S, Fujita K, Morishita T, et al. Association of the Geriatric 8 with treatment intensity and prognosis in older patients with diffuse large B‐cell lymphoma. Br J Haematol. 2021;194(2):325‐335. doi:10.1111/bjh.17554
Miura K, Konishi J, Miyake T, et al. A host‐dependent prognostic model for elderly patients with diffuse large B‐cell lymphoma. Oncologist. 2017;22(5):554‐560. doi:10.1634/theoncologist.2016‐0260
Sorror ML, Maris MB, Storb R, et al. Hematopoietic cell transplantation (HCT)‐specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 2005;106(8):2912‐2919. doi:10.1182/blood‐2005‐05‐2004
De La Rubia J, González B, Cruz‐Jentoft AJ, et al. Geriatric assessment in hematology scale predicts treatment tolerability in older patients diagnosed with hematological malignancies: the RETROGAH study. J Geriatr Oncol 2023;14(1):101401. doi:10.1016/j.jgo.2022.10.016
Giri S, Al‐Obaidi M, Harmon C, et al. Patient‐reported geriatric assessment‐based frailty index among older adults with gastrointestinal malignancies. J Am Geriatr Soc. 2023;71(1):136‐144. doi:10.1111/jgs.18054
Artz A, Logan BR, Saber W, et al. The Composite Health Risk Assessment Model (CHARM) to predict 1‐year non‐relapse mortality (NRM) among older recipients of allogeneic transplantation: a prospective BMT‐CTN study 1704 [abstract]. Blood. 2023;142(suppl 1):109. doi:10.1182/blood‐2023‐173855
Hamaker M, Lund C, Te Molder M, et al. Geriatric assessment in the management of older patients with cancer—a systematic review (update). J Geriatr Oncol. 2022;13(6):761‐777. doi:10.1016/j.jgo.2022.04.008[
Corre R, Greillier L, Le Caër H, et al. Use of a comprehensive geriatric assessment for the management of elderly patients with advanced non–small‐cell lung cancer: the phase III randomized ESOGIA‐GFPC‐GECP 08‐02 study. J Clin Oncol. 2016;34(13):1476‐1483. doi:10.1200/JCO.2015.63.5839[
Merli F, Luminari S, Rossi G, et al. Cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab versus epirubicin, cyclophosphamide, vinblastine, prednisone and rituximab for the initial treatment of elderly “fit” patients with diffuse large B‐cell lymphoma: results from the ANZINTER3 trial of the Intergruppo Italiano Linfomi. Leuk Lymphoma. 2012;53(4):581‐588. doi:10.3109/10428194.2011.621565[
Bhatt VR, Wichman C, Al‐Kadhimi ZS, et al. Integrating geriatric assessment and genetic profiling to personalize therapy selection in older adults with acute myeloid leukemia. J Geriatr Oncol. 2022;13(6):871‐874. doi:10.1016/j.jgo.2022.04.005[
Dotan E, Catalano P, Lenchik L, et al. The GIANT trial (ECOG‐ACRIN EA2186) methods paper: a randomized phase II study of gemcitabine and nab‐paclitaxel compared with 5‐fluorouracil, leucovorin, and liposomal irinotecan in older patients with treatment‐naïve metastatic pancreatic cancer—defining a new treatment option for older vulnerable patients. J Geriatr Oncol. 2023;14(3):101474. doi:10.1016/j.jgo.2023.101474[
Magnuson A, Van der Walde N, McKoy JM, et al. Integrating geriatric assessment measures into National Cancer Institute clinical trials. J Natl Cancer Inst Monogr. 2022;2022(60):142‐150. doi:10.1093/jncimonographs/lgac021[
Fried TR, Bradley EH, Towle VR, Allore H. Understanding the treatment preferences of seriously ill patients. N Engl J Med. 2002;346(14):1061. doi:10.1056/NEJMsa012528[
Loh KP, Mohile SG, Epstein RM, et al. Willingness to bear adversity and beliefs about the curability of advanced cancer in older adults. Cancer. 2019;125(14):2506‐2513. doi:10.1002/cncr.32074[
Soto‐Perez‐de‐Celis E, Dale W, Katheria V, et al. Outcome prioritization and preferences among older adults with cancer starting chemotherapy in a randomized clinical trial. Cancer. 2024;130:3000‐3010. doi:10.1002/cncr.35333[
Anwar MR, Yeretzian ST, Ayala AP, et al. Effectiveness of geriatric assessment and management in older cancer patients: a systematic review and meta‐analysis. J Natl Cancer Inst. 2023;115(12):1483‐1496. doi:10.1093/jnci/djad200[
Li D, Sun CL, Kim H, et al. Geriatric Assessment–Driven Intervention (GAIN) on chemotherapy‐related toxic effects in older adults with cancer: a randomized clinical trial. JAMA Oncol. 2021;7(11):e214158. doi:10.1001/jamaoncol.2021.4158[
Lund CM, Vistisen KK, Olsen AP, et al. The effect of geriatric intervention in frail older patients receiving chemotherapy for colorectal cancer: a randomised trial (GERICO). Br J Cancer. 2021;124(12):1949‐1958. doi:10.1038/s41416‐021‐01367‐0[
Soo WK, King MT, Pope A, Parente P, Dārziņš P, Davis ID. Integrated Geriatric Assessment and Treatment Effectiveness (INTEGERATE) in older people with cancer starting systemic anticancer treatment in Australia: a multicentre, open‐label, randomised controlled trial. Lancet Healthy Longev. 2022;3(9):e617‐e627. doi:10.1016/S2666‐7568(22)00169‐6
Ørum M, Eriksen SV, Gregersen M, et al. The impact of a tailored follow‐up intervention on comprehensive geriatric assessment in older patients with cancer—a randomised controlled trial. J Geriatr Oncol. 2021;12(1):41‐48. doi:10.1016/j.jgo.2020.07.011
Puts M, Alqurini N, Strohschein F, et al. Impact of geriatric assessment and management on quality of life, unplanned hospitalizations, toxicity, and survival for older adults with cancer: the randomized 5C trial. J Clin Oncol. 2023;41(4):847‐858. doi:10.1200/jco.22.01007
Paillaud E, Brugel L, Bertolus C, et al. Effectiveness of geriatric assessment‐driven interventions on survival and functional and nutritional status in older patients with head and neck cancer: a randomized controlled trial (EGeSOR). Cancers (Basel). 2022;14(13):3290. doi:10.3390/cancers14133290
Mohile SG, Mohamed MR, Xu H, et al. Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster‐randomised study. Lancet. 2021;398(10314):1894‐1904. doi:10.1016/S0140‐6736(21)01789‐X
Mohile SG, Epstein RM, Hurria A, et al. Communication with older patients with cancer using geriatric assessment: a cluster‐randomized clinical trial from the National Cancer Institute Community Oncology Research Program. JAMA Oncol. 2020;6(2):196. doi:10.1001/jamaoncol.2019.4728
DuMontier C, Uno H, Hshieh T, et al. Randomized controlled trial of geriatric consultation versus standard care in older adults with hematologic malignancies. Haematologica. 2022;107(5):1172‐1180. doi:10.3324/haematol.2021.278802
Culakova E, Mohile SG, Peppone L, et al. Effects of a geriatric assessment intervention on patient‐reported symptomatic toxicity in older adults with advanced cancer. J Clin Oncol. 2023;41(4):835‐846. doi:10.1200/JCO.22.00738
Mohamed MR, Kyi K, Mohile SG, et al. Prevalence of and factors associated with treatment modification at first cycle in older adults with advanced cancer receiving palliative treatment. J Geriatr Oncol. 2021;12(8):1208‐1213. doi:10.1016/j.jgo.2021.06.007
Gajra A, Jeune‐Smith Y, Fortier S, et al. The use and knowledge of validated geriatric assessment instruments among US community oncologists. JCO Oncol Pract. 2022;18(7):e1081‐e1090. doi:10.1200/op.21.00743
Mohile SG, Velarde C, Hurria A, et al. Geriatric assessment‐guided care processes for older adults: a Delphi consensus of geriatric oncology experts. J Natl Comp Canc Netw. 2015;13(9):1120‐1130. doi:10.6004/jnccn.2015.0137
DuMontier C, Loh KP, Bain PA, et al. Defining undertreatment and overtreatment in older adults with cancer: a scoping literature review. J Clin Oncol. 2020;38(22):2558‐2569. doi:10.1200/jco.19.02809[
Williams GR, Hopkins JO, Klepin HD, et al. Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO guideline questions and answers. JCO Oncol Pract. 2023;19(9):718‐723. doi:10.1200/op.23.00263[
Plotkin E, Dotan E, Nightingale G. Growing need demands new approaches to caring for older adults with cancer. Oncol Issues. 2019;34(5):62‐67.
Williams GR, Weaver KE, Lesser GJ, et al. Capacity to provide geriatric specialty care for older adults in community oncology practices. Oncologist. 2020;25(12):1032‐1038. doi:10.1634/theoncologist.2020‐0189[
Verduzco‐Aguirre HC, Bolaño Guerra LM, Culakova E, et al. Barriers and facilitators for the implementation of geriatric oncology principles in Mexico: a mixed‐methods study. JCO Glob Oncol. 2022;8:e2100390. doi:10.1200/go.21.00390
Swartz K, Chapman A, Zhan T, Wen KY. Process evaluation of a G8 screening tool implementation in an outpatient oncology center. J Geriatr Oncol. 2024;15(1):101605. doi:10.1016/j.jgo.2023.101605
Klepin HD, Geiger AM, Tooze JA, et al. The feasibility of inpatient geriatric assessment for older adults receiving induction chemotherapy for acute myelogenous leukemia. J Am Geriatr Soc. 2011;59(10):1837‐1846. doi:10.1111/j.1532‐5415.2011.03614.x
Ritchie EK, Klepin HD, Storrick E, et al. Geriatric assessment for older adults receiving less‐intensive therapy for acute myeloid leukemia: report of CALGB 361101. Blood Adv. 2022;6(12):3812‐3820. doi:10.1182/bloodadvances.2021006872
Klepin HD, Ritchie E, Major‐Elechi B, et al. Geriatric assessment among older adults receiving intensive therapy for acute myeloid leukemia: report of CALGB 361006 (Alliance). J Geriatr Oncol. 2020;11(1):107‐113. doi:10.1016/j.jgo.2019.10.002
Williams GR, Deal AM, Jolly TA, et al. Feasibility of geriatric assessment in community oncology clinics. J Geriatr Oncol. 2014;5(3):245‐251. doi:10.1016/j.jgo.2014.03.001
Hurria A, Cirrincione CT, Muss HB, et al. Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401. J Clin Oncol. 2011;29(10):1290‐1296. doi:10.1200/JCO.2010.30.6985
Bellera CA, Rainfray M, Mathoulin‐Pélissier S, et al. Screening older cancer patients: first evaluation of the G‐8 geriatric screening tool. Ann Oncol. 2012;23(8):2166‐2172. doi:10.1093/annonc/mdr587
Saliba D, Elliott M, Rubenstein LZ, et al. The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community. J Am Geriatr Soc. 2001;49(12):1691‐1699. doi:10.1046/j.1532‐5415.2001.49281.x
Garcia MV, Agar MR, Soo WK, To T, Phillips JL. Screening tools for identifying older adults with cancer who may benefit from a geriatric assessment: a systematic review. JAMA Oncol. 2021;7(4):616. doi:10.1001/jamaoncol.2020.6736
Van Walree IC, Vondeling AM, Vink GR, et al. Development of a self‐reported version of the G8 screening tool. J Geriatr Oncol. 2019;10(6):926‐930. doi:10.1016/j.jgo.2019.08.011
Soubeyran P, Bellera C, Goyard J, et al. Screening for vulnerability in older cancer patients: the ONCODAGE prospective multicenter cohort study. PLoS One. 2014;9(12):e115060. doi:10.1371/journal.pone.0115060
Chakiba C, Bellera C, Etchepare F, Mathoulin‐Pelissier S, Rainfray M, Soubeyran P. The prognostic value of G8 for functional decline. J Geriatr Oncol. 2019;10(6):921‐925. doi:10.1016/j.jgo.2018.12.004
Banna GL, Basso U, Giunta EF, et al. The Geriatric G8 score is associated with survival outcomes in older patients with advanced prostate cancer in the ADHERE prospective study of the Meet‐URO Network. Curr Oncol. 2022;29(10):7745‐7753. doi:10.3390/curroncol29100612
González Serrano A, Laurent M, Barnay T, et al. A two‐step frailty assessment strategy in older patients with solid tumors: a decision curve analysis. J Clin Oncol. 2023;41(4):826‐834. doi:10.1200/jco.22.01118
Mac Eochagain C, Barrell A, Slavova‐Boneva V, et al. Implementation of a geriatric oncology service at the Royal Marsden Hospital. J Geriatr Oncol. 2024;15(2):101698. doi:10.1016/j.jgo.2023.101698
Vinod S, Khoo A, Berry M, et al. Implementation and evaluation of a geriatric‐oncology model of care for older adults with lung cancer. J Geriatr Oncol. 2023;14(8):101578. doi:10.1016/j.jgo.2023.101578
de Barros LPL, de Oliveira Muniz Koch L, de Oliveira Lima JT, et al. Development of geriatric oncology in Latin America: a report from the Latin American Cooperative Oncology Group. J Geriatr Oncol. 2024;15(3):101642. doi:10.1016/j.jgo.2023.101642
Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6(1):42. doi:10.1186/1748‐5908‐6‐42
Harmon C, Fowler M, Giri S, et al. Implementation of the Web‐Enabled Cancer & Aging Resilience Evaluation (WeCARE) in an outpatient oncology setting. J Geriatr Oncol. 2023;14(8):101644. doi:10.1016/j.jgo.2023.101644
Rosko AE, Steer C, Chien LC, et al. The Cancer and Aging Research Group (CARG) infrastructure: the clinical implementation core. J Geriatr Oncol. 2021;12(8):1164‐1165. doi:10.1016/j.jgo.2021.04.001
Sedrak MS, Freedman RA, Cohen HJ, et al. Older adult participation in cancer clinical trials: a systematic review of barriers and interventions. CA Cancer J Clin. 2021;71(1):78‐92. doi:10.3322/caac.21638
Hurria A, Akiba C, Kim J, et al. Reliability, validity, and feasibility of a computer‐based geriatric assessment for older adults with cancer. J Oncol Pract. 2016;12(12):e1025‐e1034. doi:10.1200/JOP.2016.013136
Ball C, Francis J, Huang KT, Kadylak T, Cotten SR, Rikard RV. The physical–digital divide: exploring the social gap between digital natives and physical natives. J Appl Gerontol. 2019;38(8):1167‐1184. doi:10.1177/0733464817732518
Li W, Ornstein K, Li Y, Liu B. Technology use among cancer patients pre‐ and post‐ COVID‐19 pandemic: the role of dementia. Innov Aging. 2021;5(suppl):688. doi:10.1093/geroni/igab046.2584
Pew Research Center. Mobile Fact Sheet. Pew Research Center; 2021. Accessed January 21, 2024. https://www.pewresearch.org/internet/fact‐sheet/mobile/
Pew Research Center. Internet, Broadband Fact Sheet. Pew Research Center; 2021. Accessed January 21, 2024. https://www.pewresearch.org/internet/fact‐sheet/internet‐broadband/
Anthony D, Singer D, Kirch M, et al. Use and Experiences with Patient Portals Among Older Adults. University of Michigan National Poll on Healthy Aging; 2023. Accessed January 21, 2024. https://www.healthyagingpoll.org/reports‐more/report/use‐and‐experiences‐patient‐portals‐among‐older‐adults
Lee P, Aikens J, Richardson C, et al. Mobile Health App Use Among Older Adults. University of Michigan National Poll on Healthy Aging; 2022. Accessed January 21, 2024. https://www.healthyagingpoll.org/reports‐more/report/mobile‐health‐app‐use‐among‐older‐adults
Cook S, Munteanu C, Papadopoulos E, et al. The development of an electronic geriatric assessment tool: Comprehensive Health Assessment for My Plan (CHAMP). J Geriatr Oncol. 2023;14(1):101384. doi:10.1016/j.jgo.2022.09.013
VanderWalde NA, Williams GR. Developing an electronic geriatric assessment to improve care of older adults with cancer receiving radiotherapy. Tech Innov Patient Support Radiat Oncol. 2020;16:24‐29. doi:10.1016/j.tipsro.2020.09.002
Shahrokni A, Tin A, Downey RJ, et al. Electronic rapid fitness assessment: a novel tool for preoperative evaluation of the geriatric oncology patient. J Natl Compr Canc Netw. 2017;15(2):172‐179. doi:10.6004/jnccn.2017.0018
LoCastro M, Sanapala C, Wang Y, et al. Patient‐centered communication tool for older patients with acute myeloid leukemia, their caregivers, and oncologists: a single‐arm pilot study. Cancer Med. 2023;12(7):8581‐8593. doi:10.1002/cam4.5547
Loh KP, McHugh C, Mohile SG, et al. Using information technology in the assessment and monitoring of geriatric oncology patients. Curr Oncol Rep. 2018;20(3):25. doi:10.1007/s11912‐018‐0672‐3
DiGiovanni G, Mousaw K, Lloyd T, et al. Development of a telehealth geriatric assessment model in response to the COVID‐19 pandemic. J Geriatr Oncol. 2020;11(5):761‐763. doi:10.1016/j.jgo.2020.04.007
Bergerot CD, Bergerot PG, Razavi M, et al. Implementation and evaluation of a remote geriatric assessment and intervention program in Brazil. Cancer. 2023;129(13):2095‐2102. doi:10.1002/cncr.34759
Wall SA, Knauss B, Compston A, et al. Multidisciplinary telemedicine and the importance of being seen. J Geriatr Oncol. 2020;11(8):1349‐1351. doi:10.1016/j.jgo.2020.05.006
Loh KP, Wang Y, Yilmaz S, et al. Information technology and telemedicine services in community oncology practices. JCO Clin Cancer Inform. 2023;7:e2300086. doi:10.1200/cci.23.00086
Chien L, Roberts E, Soto‐Perez‐de‐Celis E, et al. Telehealth in geriatric oncology: a novel approach to deliver multidisciplinary care for older adults with cancer. J Geriatr Oncol. 2020;11(2):197‐199. doi:10.1016/j.jgo.2019.06.011
Alexander K, Hamlin PA, Tew WP, et al. Development and implementation of an interdisciplinary telemedicine clinic for older patients with cancer—preliminary data. J Am Geriatr Soc. 2023;71(5):1638‐1649. doi:10.1111/jgs.18267
Sanapala C, Jensen‐Battaglia M, Watson EE, et al. In‐person and virtual assessment of short physical performance battery test in older adults with myeloid malignancies. Blood Adv. 2023;7(16):4414‐4417. doi:10.1182/bloodadvances.2022009396
Piraux E, Caty G, Reychler G, Forget P, Deswysen Y. Feasibility and preliminary effectiveness of a tele‐prehabilitation program in esophagogastric cancer patients. J Clin Med. 2020;9(7):2176. doi:10.3390/jcm9072176
Chen M, Mohd Said N, Mohd Rais NC, et al. Remaining agile in the COVID‐19 pandemic healthcare landscape—how we adopted a hybrid telemedicine geriatric oncology care model in an academic tertiary cancer center. J Geriatr Oncol. 2022;13(6):856‐861. doi:10.1016/j.jgo.2022.04.006
Rocque G, Wheeler S, Williams GR. The missing voice in multidisciplinary tumor boards. J Geriatr Oncol. 2021;12(8):1157‐1158. doi:10.1016/j.jgo.2021.03.004
Loh KP, Ramsdale E, Culakova E, et al. Novel mHealth app to deliver geriatric assessment‐driven interventions for older adults with cancer: pilot feasibility and usability study. JMIR Cancer. 2018;4(2):e10296. doi:10.2196/10296
Soto‐Perez‐De‐Celis E, Kim H, Rojo‐Castillo MP, et al. A pilot study of an accelerometer‐equipped smartphone to monitor older adults with cancer receiving chemotherapy in Mexico. J Geriatr Oncol. 2018;9(2):145‐151. doi:10.1016/j.jgo.2017.09.008
Feng G, Parthipan M, Breunis H, et al. Daily physical activity monitoring in older adults with metastatic prostate cancer on active treatment: feasibility and associations with toxicity. J Geriatr Oncol. 2023;14(7):101576. doi:10.1016/j.jgo.2023.101576
Loh KP, Sanapala C, Watson EE, et al. A single‐arm pilot study of a mobile health exercise intervention (GO‐EXCAP) in older patients with myeloid neoplasms. Blood Adv. 2022;6(13):3850‐3860. doi:10.1182/bloodadvances.2022007056
Nipp RD, Horick NK, Deal AM, et al. Differential effects of an electronic symptom monitoring intervention based on the age of patients with advanced cancer. Ann Oncol. 2020;31(1):123‐130. doi:10.1016/j.annonc.2019.09.003
Qiao EM, Qian AS, Nalawade V, et al. Evaluating high‐dimensional machine learning models to predict hospital mortality among older patients with cancer. JCO Clin Cancer Inform. 2022;(6):e2100186. doi:10.1200/CCI.21.00186
Ramsdale E, Kunduru M, Smith L, et al. Supervised learning applied to classifying fallers versus non‐fallers among older adults with cancer. J Geriatr Oncol. 2023;14(4):101498. doi:10.1016/j.jgo.2023.101498
Venkatesh KP, Raza MM, Kvedar JC. Health digital twins as tools for precision medicine: considerations for computation, implementation, and regulation. NPJ Digit Med. 2022;5(1):150, doi:10.1038/s41746‐022‐00694‐7
Wilkinson MD, Dumontier M, Aalbersberg IJ, et al. The FAIR Guiding Principles for scientific data management and stewardship. Sci Data. 2016;3(1):160018. doi:10.1038/sdata.2016.18
21st Century Cures Act: Interoperability, Information Blocking, and the ONC Health IT Certification Program. 85 Federal Register 25642‐25961. 2020.
Herington J, McCradden MD, Creel K, et al. Ethical considerations for artificial intelligence in medical imaging: data collection, development, and evaluation. J Nucl Med. 2023;64(12):1848‐1854. doi:10.2967/jnumed.123.266080
Fox‐Grage W. The Growing Racial and Ethnic Diversity of Older Adults. AARP Blogs; March 7, 2016, Accessed January 21, 2024. https://blog.aarp.org/thinking‐policy/the‐growing‐racial‐and‐ethnic‐diversity‐of‐older‐adults
Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12‐49. doi:10.3322/caac.21820
National Center for Health Statistics. Healthy People 2020. Centers for Disease Control and Prevention; 2021.
Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol. 2009;27(17):2758‐2765. doi:10.1200/JCO.2008.20.8983
Mandelblatt JS, Ruterbusch JJ, Thompson HS, et al. Association between major discrimination and deficit accumulation in African American cancer survivors: the Detroit Research on Cancer Survivors study. Cancer. 2023;129(10):1557‐1568. doi:10.1002/cncr.34673
Hastert TA, Kyko JM, Reed AR, et al. Financial hardship and quality of life among African American and white cancer survivors: the role of limiting care due to cost. Cancer Epidemiol Biomarkers Prev. 2019;28(7):1202‐1211. doi:10.1158/1055‐9965.EPI‐18‐1336
Jones NL, Gilman SE, Cheng TL, Drury SS, Hill CV, Geronimus AT. Life course approaches to the causes of health disparities. Am J Public Health. 2019;109(S1):S48‐S55. doi:10.2105/AJPH.2018.304738
Braveman P, Gottlieb L. The social determinants of health: it's time to consider the causes of the causes. Public Health Rep. 2014;129(1 suppl 2):19‐31. doi:10.1177/00333549141291S206
Dotan E, Lynch SM, Ryan JC, Mitchell EP. Disparities in care of older adults of color with cancer: a narrative review. Cancer Med. 2024;13(3):e6790. doi:10.1002/cam4.6790
Williams GR, Fowler M, Giri S, et al. Association of unmet basic resource needs with frailty and quality of life among older adults with cancer—results from the CARE registry. Cancer Med. 2023;12(12):13846‐13855. doi:10.1002/cam4.6038
Williams GR, Al‐Obaidi M, Harmon C, et al. Racial disparities in frailty and geriatric assessment impairments in older adults with cancer in the Deep South: results from the CARE registry. Cancer. 2022;128(12):2313‐2319. doi:10.1002/cncr.34178
Zavala VA, Bracci PM, Carethers JM, et al. Cancer health disparities in racial/ethnic minorities in the United States. Br J Cancer. 2021;124(2):315‐332. doi:10.1038/s41416‐020‐01038‐6
Sengupta R, Honey K. AACR Cancer Disparities Progress Report 2020: achieving the bold vision of health equity for racial and ethnic minorities and other underserved populations. Cancer Epidemiol Biomarkers Prev. 2020;29(10):1843. doi:10.1158/1055‐9965.EPI‐20‐0269
Phillips T, Sun C, Chien L, et al. Geriatric Assessment‐Directed Supportive Care Intervention (GAIN‐S)‐implementation via telehealth in a lower‐resourced community [abstract]. 2024;42(16 suppl):1510, doi:10.1200/jco.2024.42.16_suppl.1510
Roth R, Barsi E. The Community Need Index. A new tool pinpoints health care disparities in communities throughout the nation. Health Prog. 2005;86(4):32‐38.
Kind AJH, Buckingham WR. Making neighborhood‐disadvantage metrics accessible—The Neighborhood Atlas. N Engl J Med. 2018;378(26):2456‐2458. doi:10.1056/NEJMp1802313
Flanagan BE, Gregory EW, Hallisey EJ, Heitgerd JL, Lewis B. A social vulnerability index for disaster management. J Homeland Secur Emerg Manage. 2011;8(1):Article 3. doi:10.2202/1547‐7355.1792
Ponce NA, Hays RD, Cunningham WE. Linguistic disparities in health care access and health status among older adults. J Gen Intern Med. 2006;21(7):786‐791. doi:10.1111/j.1525‐1497.2006.00491.x
Haldar S, Pillai D, Artiga S. Overview of Health Coverage and care for Individuals with Limited English Proficiency (LEP). Kaiser Family Foundation; 2023. Accessed January 21, 2024. https://www.kff.org/6c186f7/
Qian AS, Schiaffino MK, Nalawade V, et al. Disparities in telemedicine during COVID‐19. Cancer Med. 2022;11(4):1192‐1201. doi:10.1002/cam4.4518
De B, Maroongroge S, Smith GL. Letter to the editor regarding “disparities in telemedicine during COVID‐19.” Cancer Med. 2023;12(2):1556‐1557. doi:10.1002/cam4.5036
Chen DW, Banerjee M, He X, et al. Hidden disparities: how language influences patients' access to cancer care. J Natl Compr Canc Netw. 2023;21(9):951‐959.e1. doi:10.6004/jnccn.2023.7037
Schiaffino MK, Nara A, Mao L. Language services in hospitals vary by ownership and location. Health Affairs (Millwood). 2016;35(8):1399‐1403. doi:10.1377/hlthaff.2015.0955
Leung B, Pilleron S, Bastiaannet E, et al. Cancer treatment‐related decision‐making among culturally and linguistically diverse older adults with cancer: a scoping review by the International Society of Geriatric Oncology Nursing and Allied Health Interest Group. J Geriatr Oncol. 2023;14(8):101607. doi:10.1016/j.jgo.2023.101607
Yilmaz S, Sanapala C, Schiaffino MK, et al. Social justice and equity: why older adults with cancer belong—a life course perspective. Am Soc Clin Oncol Educ Book. 2022;(42):402‐414. doi:10.1200/EDBK_349825
Patel MI, Lopez AM, Blackstock W, et al. Cancer disparities and health equity: a policy statement from the American Society of Clinical Oncology. J Clin Oncol. 2020;38(29):3439‐3448. doi:10.1200/JCO.20.00642
Gilmore N, Grant SJ, Bethea TN, et al. A scoping review of racial, ethnic, socioeconomic, and geographic disparities in the outcomes of older adults with cancer. J Am Geriatr Soc, 2024;72(6):1867‐1900. doi:10.1111/jgs.18881
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Care Services; Committee on Integrating Social Needs Care into the Delivery of Health Care to Improve the Nation's Health. Integrating Social Care into the Delivery of Health Care: Moving Upstream to Improve The Nation's Health. National Academies Press; 2019.
Tucker‐Seeley RD, Wallington SF, Canin B, Tang W, McKoy JM. Health equity for older adults with cancer. J Clin Oncol. 2021;39(19):2205‐2216. doi:10.1200/JCO.21.00207
Erikson C, Salsberg E, Forte G, Bruinooge S, Goldstein M. Future supply and demand for oncologists: challenges to assuring access to oncology services. J Oncol Pract. 2007;3(2):79‐86. doi:10.1200/JOP.0723601
McKoy JM, Samaras AT, Bennett CL. Providing cancer care to a graying and diverse cancer population in the 21st century: are we prepared? J Clin Oncol. 2009;27(17):2745‐2746. doi:10.1200/JCO.2009.22.4352
Wallington SF, Brawley OW, Holmes MD. Socioeconomic status and breast cancer disparities. In: Koh HK, ed. Toward the Elimination of Cancer Disparities. Springer; 2009:137‐160.
Committee on Family Caregiving for Older Adults; Board on Health Care Services; Health and Medicine Division; National Academies of Sciences, Engineering, and Medicine; Schulz R, Eden J, eds. Families Caring for an Aging America. National Academies Press; 2016.
Hsu T, Loscalzo M, Ramani R, et al. Factors associated with high burden in caregivers of older adults with cancer. Cancer. 2014;120(18):2927‐2935. doi:10.1002/cncr.28765
Mollica MA, Litzelman K, Rowland JH, Kent EE. The role of medical/nursing skills training in caregiver confidence and burden: a CanCORS study. Cancer. 2017;123(22):4481‐4487. doi:10.1002/cncr.30875
Ge L, Mordiffi SZ. Factors associated with higher caregiver burden among family caregivers of elderly cancer patients: a systematic review. Cancer Nurs. 2017;40(6):471‐478. doi:10.1097/NCC.0000000000000445
Thana K, Lehto R, Sikorskii A, Wyatt G. Informal caregiver burden for solid tumour cancer patients: a review and future directions. Psychol Health. 2021;36(12):1514‐1535. doi:10.1080/08870446.2020.1867136
Zarit S, Todd P, Zarit J. Subjective burdens of husbands and wives as caregivers: a longitudinal study:. Alzheimer Dis Assoc Disord. 1987;1(2):109‐110. doi:10.1097/00002093‐198701020‐00026
Jayani R, Hurria A. Caregivers of older adults with cancer. Semin Oncol Nurs. 2012;28(4):221‐225. doi:10.1016/j.soncn.2012.09.004
Kehoe LA, Xu H, Duberstein P, et al. Quality of life of caregivers of older patients with advanced cancer. J Am Geriatr Soc. 2019;67(5):969‐977. doi:10.1111/jgs.15862
Kadambi SG, Stupia L, Wang L, et al. Feasibility of the geriatric assessment in older caregivers of older adults with cancer to guide supportive care. JCO Oncol Pract. 2023;19(11 suppl):224‐224. doi:10.1200/OP.2023.19.11_suppl.224
Navaie‐Waliser M, Feldman PH, Gould DA, Levine C, Kuerbis AN, Donelan K. When the caregiver needs care: the plight of vulnerable caregivers. Am J Public Health. 2002;92(3):409‐413. doi:10.2105/AJPH.92.3.409
Schulz R, Beach SR. Caregiving as a risk factor for mortality: the Caregiver Health Effects study. JAMA. 1999;282(23):2215. doi:10.1001/jama.282.23.2215
Beesley VL, Price MA, Webb PM. Loss of lifestyle: health behaviour and weight changes after becoming a caregiver of a family member diagnosed with ovarian cancer. Support Care Cancer. 2011;19(12):1949‐1956. doi:10.1007/s00520‐010‐1035‐2
National Alliance for Caregiving. Evercare® Study of Caregivers in Decline: A Close‐up Look at the Health Risks of Caring for a Loved One. Evercare; 2006.
Kuzuya M, Enoki H, Hasegawa J, et al. Impact of caregiver burden on adverse health outcomes in community‐dwelling dependent older care recipients. Am J Geriatr Psychiatry. 2011;19(4):382‐391. doi:10.1097/JGP.0b013e3181e9b98d
Tsai CF, Lee YT, Lee WJ, Hwang JP, Wang SJ, Fuh JL. Depression of family caregivers is associated with disagreements on life‐sustaining preferences for treating patients with dementia. PLoS One. 2015;10(7):e0133711. doi:10.1371/journal.pone.0133711
Epstein‐Lubow G, Gaudiano BA, Hinckley M, Salloway S, Miller IW. Evidence for the validity of the American Medical Association's caregiver self‐assessment questionnaire as a screening measure for depression. J Am Geriatr Soc. 2010;58(2):387‐388. doi:10.1111/j.1532‐5415.2009.02701.x
Thornton M, Travis SS. Analysis of the reliability of the modified caregiver strain index. J Gerontol B Psychol Sci Soc Sci. 2003;58(2):S127‐S132. doi:10.1093/geronb/58.2.S127
Shaffer KM, Benvengo S, Zalket AK, et al. Feasibility and acceptability of distress screening for family caregivers at a cancer surgery center. Oncol Nurs Forum. 2019;46(2):159‐169. doi:10.1188/19.ONF.159‐169
Ugalde A, Gaskin CJ, Rankin NM, et al. A systematic review of cancer caregiver interventions: appraising the potential for implementation of evidence into practice. Psychooncology. 2019;28(4):687‐701. doi:10.1002/pon.5018
Chow R, Mathews JJ, Cheng EY, et al. Interventions to improve outcomes for caregivers of patients with advanced cancer: a meta‐analysis. J Natl Cancer Inst. 2023;115(8):896‐908. doi:10.1093/jnci/djad075
Northouse LL, Katapodi MC, Song L, Zhang L, Mood DW. Interventions with family caregivers of cancer patients: meta‐analysis of randomized trials. CA Cancer J Clin. 2010;60(5):317‐339. doi:10.3322/caac.20081
Thomas TH, Campbell GB, Lee YJ, et al. Priorities to improve cancer caregiving: report of a caregiver stakeholder workshop. Support Care Cancer. 2021;29(5):2423‐2434. doi:10.1007/s00520‐020‐05760‐y